ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,314.01
0.11%
Dow Jones
39,883.44
0.19%
US Dollar vs MXN
16.58172
0.16%
Brent Oil
83.035
-0.59%
Bitcoin
70,311.63
-1.59%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cytocom Inc (CBLI)

  7. Cytocom Inc (CBLI) Noticias

CBLI

Cytocom (CBLI)

Cytocom Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CBLI
FechaHoraFuenteTítuloSímboloCompañía
03/03/202309:47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CBLICytocom Inc
27/02/202305:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CBLICytocom Inc
15/02/202308:10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CBLICytocom Inc
01/02/202315:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBLICytocom Inc
01/02/202315:10Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)NASDAQ:CBLICytocom Inc
14/11/202216:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBLICytocom Inc
06/10/202205:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CBLICytocom Inc
23/09/202205:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CBLICytocom Inc
22/03/202206:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CBLICytocom Inc
21/03/202218:27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBLICytocom Inc
15/02/202205:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBLICytocom Inc
30/09/202115:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBLICytocom Inc
31/08/202106:32PR Newswire (US)Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."NASDAQ:CBLICytocom Inc
16/08/202109:34PR Newswire (US)Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via WebcastNASDAQ:CBLICytocom Inc
16/08/202106:30PR Newswire (US)Cytocom, Inc. Reports Second Quarter 2021 Financial ResultsNASDAQ:CBLICytocom Inc
12/08/202115:05PR Newswire (US)Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance AgreementNASDAQ:CBLICytocom Inc
11/08/202106:30PR Newswire (US)Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business ConferenceNASDAQ:CBLICytocom Inc
10/08/202106:30PR Newswire (US)Cytocom, Inc. to Report Second Quarter 2021 Financial ResultsNASDAQ:CBLICytocom Inc
09/08/202106:30PR Newswire (US)Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19NASDAQ:CBLICytocom Inc
05/08/202106:33PR Newswire (US)Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabsNASDAQ:CBLICytocom Inc
29/07/202106:33PR Newswire (US)Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt FinancingNASDAQ:CBLICytocom Inc
06/07/202108:16PR Newswire (US)Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed MergerNASDAQ:CBLICytocom Inc
17/06/202117:37PR Newswire (US)Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Decl...NASDAQ:CBLICytocom Inc
11/06/202105:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CBLICytocom Inc
17/02/202115:17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CBLICytocom Inc
17/02/202115:15PR Newswire (US)Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc.NASDAQ:CBLICytocom Inc
22/12/202006:35PR Newswire (US)Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"NASDAQ:CBLICytocom Inc
11/11/202008:11InvestorsHub NewsWireImmune Therapeutics, Inc. Spinoff Cytocom, Inc. Appoints BioPharm Industry Veteran as New Chief Operating OfficerNASDAQ:CBLICytocom Inc
06/11/202016:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBLICytocom Inc
27/10/202012:14InvestorsHub NewsWireImmune Therapeutics, Inc. Announces Cytocom Conference CallNASDAQ:CBLICytocom Inc
 Showing the most relevant articles for your search:NASDAQ:CBLI

Su Consulta Reciente

NYSE
NKE
Nike
NASDAQ
AAPL
Apple
CCOM
US500
US 500
NYSE
DIS
Walt Disney
CCOM
US30
US 30
COIN
SOLUSD
Solana
NASDAQ
MSFT
Microsoft
AMEX
XLE
Energy Select Sector SPDR
PM
XAUUSD
Gold vs US Dollar
FX
EURUSD
Euro vs US Dollar
CCOM
OILBRENT
Brent Oil
NYSE
XOM
Exxon Mobil
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
BAC
Bank of America
NYSE
CVX
Chevron
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados